678-366-7933
Store
Emergency Department Diagnosis and Management of Acetaminophen or Salicylate Toxicity
What ED Clinicians Need to Know
Acetaminophen and salicylate are among the most widely used nonprescription analgesics and are common causes of toxic medication overdose, accounting for approximately 56,000 to 78,000 ED visits and 500 deaths annually from acetaminophen, and 26,000 toxic exposures and 19,000 ED visits annually from salicylate. This issue presents a systematic, evidence-based approach to the emergency department diagnosis and management of acetaminophen and salicylate toxicity, covering both acute and chronic ingestion patterns.
Key management tools include the Rumack-Matthew nomogram to guide N-acetylcysteine (NAC) therapy in acute acetaminophen ingestion, the King's College Criteria to identify patients who need urgent liver transplant evaluation, and serial salicylate concentrations paired with urinary alkalinization and, when indicated, hemodialysis for salicylate toxicity. The issue also addresses special populations, including pregnant patients and children, and reviews controversies such as high-dose NAC and fomepizole for massive acetaminophen ingestion.
Why This Topic Matters in the ED
- Acetaminophen and salicylate overdose are among the most common causes of medication-related poisoning and death in the United States, and both are frequently implicated in intentional, suicide-related overdoses.
- Acetaminophen toxicity is frequently clinically silent even at dangerous concentrations, so the absence of symptoms should never reassure clinicians after a reported overdose.
- Chronic acetaminophen toxicity can present with an undetectable serum concentration despite severe hepatotoxicity; treatment decisions must be based on transaminase levels and clinical findings rather than the Rumack-Matthew nomogram.
- Salicylate toxicity produces a distinctive mixed acid-base disturbance, and hyperthermia or altered mental status signals severe, life-threatening toxicity that requires urgent escalation of care.
- Time-sensitive decisions such as when to draw a repeat acetaminophen level, when to initiate NAC, and when to pursue alkalinization or hemodialysis for salicylate poisoning, directly affect outcomes and are frequent sources of risk management pitfalls.
Clinical Content at a Glance
Clinical Q&A
- How are acetaminophen and salicylate toxicity diagnosed and risk-stratified in the ED?
- A serum acetaminophen concentration measured 4 hours after a single acute ingestion is plotted on the Rumack-Matthew nomogram to determine the need for NAC, while salicylate toxicity is risk-stratified using serial salicylate concentrations, acid-base status, and clinical findings.
- What are the key components of first-line management for acetaminophen or salicylate toxicity?
- Acetaminophen toxicity is treated with activated charcoal when appropriate and NAC when the concentration is on or above the nomogram treatment line or chronic toxicity is suspected. Salicylate toxicity is treated with activated charcoal, IV sodium bicarbonate for alkalinization, and potassium repletion to maintain alkalinization.
- When is escalation of care indicated for patients with severe acetaminophen or salicylate toxicity?
- Patients meeting King's College Criteria for acetaminophen-induced acute liver failure require urgent transfer to a liver transplant center, while patients with severe salicylate poisoning require emergent hemodialysis and, if intubation is unavoidable, careful preservation of their compensatory hyperventilation.
- How does chronic acetaminophen ingestion change management?
- Because the Rumack-Matthew nomogram applies only to a single acute ingestion, chronic or repeated supratherapeutic acetaminophen ingestion is managed based on history, symptoms, and transaminase levels, and NAC should be started whenever hepatotoxicity is suspected rather than withheld pending nomogram interpretation.
- What special considerations apply to pregnant patients and children?
- NAC is safe and effective in pregnancy and should be started using the same criteria as in nonpregnant patients without delay for fetal monitoring. Children with salicylate poisoning may develop profound metabolic acidosis earlier than adults and are more prone to hypoglycemia, so aggressive glucose supplementation should be considered.
Case Snapshots
CASE 1 — Acute Intentional Acetaminophen Overdose: An 18-year-old woman presents 4 hours after intentionally ingesting 10 g of acetaminophen, with a 4-hour level of 165 mcg/mL and normal AST/ALT. The issue walks through applying the Rumack-Matthew nomogram to determine whether NAC is needed before medical clearance for psychiatry.
CASE 2 — Chronic Acetaminophen Toxicity: A 40-year-old man on multiple acetaminophen-containing products for dental pain over a week develops abdominal pain, nausea, and vomiting, with elevated AST and ALT levels, and an undetectable acetaminophen level. The issue explores why the nomogram does not apply here and how NAC decisions are made for chronic ingestion.
CASE 3 — Salicylate Overdose With Tinnitus: A 25-year-old woman presents with tinnitus after taking an unknown quantity of a salicylate/caffeine combination product, with an initial salicylate level of 84 mg/dL. The issue reviews alkalinization therapy and the criteria for considering hemodialysis in salicylate poisoning.
Clinical Tools
- Table of vital sign abnormalities in acetaminophen versus salicylate toxicity
- Table of the 4 stages of acetaminophen toxicity following overdose
- Revised Rumack-Matthew nomogram
- Table of criteria for cessation of N-acetylcysteine therapy
- Tables of indications for hemodialysis in acetaminophen poisoning and in salicylate poisoning
- Table of King's College Criteria for acetaminophen-induced acute liver failure, with a link to an online calculator at MDCalc.com
- Clinical pathways for ED management of acetaminophen toxicity and of salicylate toxicity
Risk Management Pitfalls
- Failing to order salicylate or acetaminophen levels for a patient who attempted suicide because the patient reports taking only a different medication
- Relying on an acetaminophen concentration drawn <4 hours after ingestion without obtaining a repeat level at 4 hours to accurately apply the Rumack-Matthew nomogram
- Not consulting nephrology for an acidotic patient who has overdosed on salicylate to evaluate for emergent hemodialysis
- Not transferring a patient who meets King's College Criteria after acetaminophen-induced acute liver failure to a liver transplant center
- Failing to maintain a high preintubation minute ventilation in a patient with salicylate poisoning, resulting in a precipitous drop in pH after intubation
Key References
Following are the most informative references cited in this paper, as determined by the authors.
3. * Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6(8):e2327739. (Consensus-based clinical practice guideline) DOI: 10.1001/jamanetworkopen.2023.27739
5. * American College of Medical Toxicology. Guidance document: management priorities in salicylate toxicity. J Med Toxicol. 2015;11(1):149-152. (Clinical practice guideline) DOI: 10.1007/s13181-013-0362-3
19. * Shively RM, Hoffman RS, Manini AF. Acute salicylate poisoning: risk factors for severe outcome. Clin Toxicol (Phila). 2017;55(3):175-180. (Secondary analysis of prospective cohort study data; 48 patients) DOI: 10.1080/15563650.2016.1271127
23. * Rumack BH, Peterson RC, Koch GG, et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981;141(3 Spec No):380-385. (Prospective multicenter uncontrolled treatment cohort study; 662 patients) DOI: 10.1001/archinte.141.3.380
26. * Brok J, Buckley N, Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. 2006(2):CD003328. (Cochrane review; 60 studies) DOI: 10.1002/14651858.CD003328.pub2
32. * Gosselin S, Juurlink DN, Kielstein JT, et al. Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2014;52(8):856-867. (Systematic review and consensus-based clinical practice guideline; 24 studies, 135 patients) DOI: 10.3109/15563650.2014.946994
37. * Juurlink DN, Gosselin S, Kielstein JT, et al. Extracorporeal treatment for salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med. 2015;66(2):165-181. (Systematic review and consensus-based clinical practice guideline) DOI: 10.1016/j.annemergmed.2015.03.031
CME Information
- 4 CME credits (available for subscribers)
- Includes Pharmacology
- View complete CME Information here
